Select Medical/$SEM
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Select Medical
Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.
Ticker
$SEM
Sector
Primary listing
NYSE
Employees
37,050
Headquarters
Website
Select Medical Metrics
BasicAdvanced
$1.7B
15.40
$0.87
1.08
$0.31
1.86%
Price and volume
Market cap
$1.7B
Beta
1.08
52-week high
$39.73
52-week low
$11.65
Average daily volume
1.3M
Dividend rate
$0.31
Financial strength
Current ratio
1.086
Quick ratio
0.943
Long term debt to equity
127.009
Total debt to equity
137.554
Dividend payout ratio (TTM)
36.19%
Interest coverage (TTM)
2.49%
Profitability
EBITDA (TTM)
382.138
Gross margin (TTM)
17.06%
Net profit margin (TTM)
2.05%
Operating margin (TTM)
5.46%
Effective tax rate (TTM)
19.78%
Revenue per employee (TTM)
$140,000
Management effectiveness
Return on assets (TTM)
2.68%
Return on equity (TTM)
7.70%
Valuation
Price to earnings (TTM)
15.404
Price to revenue (TTM)
0.311
Price to book
0.99
Price to tangible book (TTM)
-2.24
Price to free cash flow (TTM)
9.596
Free cash flow yield (TTM)
10.42%
Free cash flow per share (TTM)
1.404
Dividend yield (TTM)
2.32%
Forward dividend yield
1.86%
Growth
Revenue change (TTM)
45.29%
Earnings per share change (TTM)
-60.96%
3-year revenue growth (CAGR)
-5.25%
10-year revenue growth (CAGR)
4.61%
3-year earnings per share growth (CAGR)
-14.21%
10-year earnings per share growth (CAGR)
-1.02%
3-year dividend per share growth (CAGR)
-9.14%
10-year dividend per share growth (CAGR)
6.49%
What the Analysts think about Select Medical
Analyst ratings (Buy, Hold, Sell) for Select Medical stock.
Bulls say / Bears say
Select Medical’s consolidated revenue for Q3 2025 rose 7.2% year-over-year to $1.3634 billion, exceeding consensus estimates and showing strong demand across its segments. (PR Newswire)
The company promoted longtime executive Thomas P. Mullin to CEO effective September 1, 2025, ensuring leadership continuity and maintaining strategic direction. (PR Newswire)
CMS’s proposed 2.8% increase in long-term care hospital payments for FY2025 is expected to raise reimbursement rates for Select Medical’s critical illness recovery hospitals, supporting margin growth. (Bloomberg Law)
Select Medical’s outpatient rehabilitation segment saw its adjusted EBITDA margin decline to 7.4% in Q3 2025 from 9.1% a year earlier, highlighting continued pressure on rates and persistent reimbursement challenges. (PR Newswire)
Adjusted EBITDA dropped by 8.6% year-over-year to $151.4 million in Q1 2025, even as revenue increased 2.4%, signaling cost pressures and margin contraction early in the year. (PR Newswire)
SEM shares are down more than 30% year-to-date, reflecting investor concerns about growth prospects amid ongoing reimbursement challenges and higher leverage. (CNBC)
Data summarised monthly by Lightyear AI. Last updated on 5 Nov 2025.
Select Medical Financial Performance
Revenues and expenses
Select Medical Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Select Medical stock?
Select Medical (SEM) has a market cap of $1.7B as of November 07, 2025.
What is the P/E ratio for Select Medical stock?
The price to earnings (P/E) ratio for Select Medical (SEM) stock is 15.4 as of November 07, 2025.
Does Select Medical stock pay dividends?
Yes, the Select Medical (SEM) stock pays dividends to shareholders. As of November 07, 2025, the dividend rate is $0.3125 and the yield is 1.86%. Select Medical has a payout ratio of 36.19% on a trailing twelve-month basis.
When is the next Select Medical dividend payment date?
The next Select Medical (SEM) dividend payment is scheduled for November 25, 2025.
What is the beta indicator for Select Medical?
Select Medical (SEM) has a beta rating of 1.08. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.